Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Svatantra Microfin has filed draft papers for an initial public offering totaling 30 billion rupees ($314.33 million). The plan calls for up to 15 billion rupees from new share issuance and an equal amount from existing shareholders Advent International and Multiples. The filing comes as India’s primary market rebounds after a weak first half of th…
Maze Therapeutics announced the addition of Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its Board of Directors, bringing extensive clinical and biopharmaceutical experience. The appointments come as the company prepares for critical clinical data readouts and trial initiations for its kidney and metabolic disease drug ca…
Gemini Space Station, Inc. (NASDAQ: GEMI) reported strong Q2 2026 results with 37% year-over-year revenue growth to $45.5 million, driven by a 149% increase in services revenue, notably credit card and staking offerings, despite a 38% decline in exchange revenue due to softer crypto markets. The company improved operating loss sequentially by 18% t…
Winnebago Industries announced strategic manufacturing realignments, relocating key production lines to consolidate operations across its Winnebago and Grand Design RV brands. These moves aim to optimize manufacturing capacity, reduce costs, and strengthen operational coordination to fuel future growth without discontinuing any product lines or dis…
Tyson Foods announced strategic restructuring of its beef business by consolidating operations into three key facilities in Nebraska, Kansas, and Texas, closing or selling others, to address ongoing cattle supply constraints and improve competitiveness. The company plans to support impacted employees during the transition and aims to maintain stabl…
TWFG, Inc. has expanded its revolving credit facility to $125 million with an extended maturity to 2031, enhancing its liquidity and financial flexibility. The credit agreement with PNC Bank includes an uncommitted accordion feature potentially increasing borrowing capacity to $200 million. This financial move supports TWFG's growth strategy throug…
LifeVantage Corporation, a leader in health and wellness products rooted in nutrigenomics, announced that it will release its fourth quarter and full fiscal year 2026 financial results on August 27, 2026. An investor conference call and webcast will follow the release to discuss the company's performance and outlook.
CaliberCos Inc. reported second quarter 2026 financial results showing Platform Adjusted EBITDA turning positive at $0.3 million, indicating progress towards profitability. Despite a decline in platform revenue to $3.7 million, the company reaffirmed full-year 2026 guidance and highlighted major milestones including the groundbreaking of its Steamb…
Calidi Biotherapeutics announced its second quarter 2026 financial results, highlighting positive FDA pre-IND feedback on its lead candidate CLD-401, progress in its RedTail oncolytic virus platform, presentation of preclinical data for CLD-501 at ASCO 2026, board expansion with industry veteran Corsee Sanders, and a 48% reduction in general and ad…
Centrus (LEU) is the only U.S. company licensed to produce HALEU fuel and today’s price action looks constructive. With a $3.8B market cap, a multi-billion backlog, and a sizable DOE contract, Centrus has both government and commercial demand pulling in the same direction. This trade idea lays out a mid-term long: entry at $192.50, stop at $170.00,…
Tempest Therapeutics announced its Q2 2026 financial results and strategic business updates, highlighting the advancement of its next-generation in vivo CAR-T platform including collaboration with Senlang Biotechnology for TPST-4003, anticipates initial clinical data in H1 2027, positive interim clinical data for TPST-2003, and corporate developmen…
CPI Aerostructures, Inc. reported substantial year-over-year improvement for Q2 and the first six months of 2026, highlighted by increased revenues, higher gross margins, and positive net income compared to losses in the prior year periods. Revenue for Q2 rose to $17.6 million from $15.2 million, with net income turning positive at $0.7 million ver…
Genelux Corporation, a clinical-stage immuno-oncology company, announced its second quarter 2026 financial results showing a net loss of $9.5 million and $18.7 million in cash reserves expected to fund operations into early 2027. The company is progressing its Olvi-Vec immunotherapy clinical trials in platinum-resistant ovarian cancer and lung canc…
Oportun has appointed Scott Scheirman to its Board of Directors, where he will chair the Audit & Risk Committee and join the Compensation & Leadership Committee. With extensive leadership experience from companies like CPI Card Group, Western Union, and Fiserv, Scheirman is expected to enhance Oportun's strategic planning and execution to support p…
Actelis Networks, Inc. reported a 20% year-over-year increase in second quarter 2026 revenues to $1.1 million with gross margins improving to 51%. The company expanded market presence across Intelligent Transportation Systems, U.S. carriers, and multi-dwelling unit markets while implementing cost reductions and operational efficiencies. Actelis is …
KULR Technology Group announced its second quarter 2026 financial results, revealing a 43% revenue decline and a significant net loss of $21.97 million, primarily due to a non-cash $10.6 million fair value loss from its bitcoin holdings. The company is refocusing on its core energy platform, exiting bitcoin mining, repaying related debt, and reduci…
Edesa Biotech announced fiscal Q3 2026 results, highlighting readiness for its Phase 2 clinical trial of EB06 for vitiligo and positive exploratory analyses of paridiprubart in ARDS patients with acute kidney injury. The company is progressing in clinical execution and engaging strategic discussions for paridiprubart's late-stage development and co…
Burlington Stores, a leading off-price retailer, will release its Q2 fiscal year 2026 earnings before the U.S. market opens on August 27, 2026. The company will host a conference call and webcast to discuss results. Burlington operates over 1,200 stores nationwide and offers branded apparel and home merchandise at discounted prices.
Akari Therapeutics reported robust Q2 2026 financials highlighted by $8.6 million in financing and progression of its lead antibody drug conjugate candidate, AKTX-101, towards a planned Phase 1 clinical trial in mid-2027. The company showcased compelling ASCO 2026 preclinical data demonstrating synergistic anti-tumor activity in KRAS-mutated pancre…
Cadrenal Therapeutics reported a net loss of $3.3 million for Q2 2026, with decreased operating expenses compared to the prior year period. The company highlighted significant clinical advances, including promising Phase 2 data for CAD-1005 reducing thrombotic events by over 25%. Cadrenal launched a strategic partnering process for its Cardiac Acut…
Innventure, Inc. reported its second quarter 2026 financial results, highlighting ongoing belief in long-term demand for two-phase liquid cooling technology driven by AI infrastructure growth. The company announced it is suspending prior 2026 revenue and cash flow targets for its Accelsius subsidiary due to changing market conditions impacting near…
Profound Medical Corp. announced the launch of 'Let's Huddle,' a global patient community aimed at supporting men diagnosed with prostate disease by providing education, peer connection, advocacy, and shared experiences throughout diagnosis, treatment, and survivorship. The initiative enhances patient-centered care alongside Profound's innovative M…
Blaize Holdings, Inc. reported Q2 2026 revenue of $12.0 million, a significant sequential increase from Q1, driven by activity in its AI computing platforms. However, the company revised its full-year revenue guidance down to $40 to $43 million due to slower order conversion and increased memory costs. Blaize secured a large server order worth appr…
Tri Pointe Homes, Inc. announced its second quarter 2026 results showing a 22.1% decline in home sales revenue to $685.1 million and a 23.6% drop in new home deliveries compared to the prior year. The quarter included significant charges related to the Sumitomo Forestry transaction totaling $196.8 million and inventory impairment charges. Adjusted …
Serina Therapeutics completed enrollment and dosing for Cohort 1 of its Phase 1b registrational study of SER-252 ahead of schedule. The single-ascending-dose data top line results are expected in the first half of 2027. The company also announced a development partnership with Gannet BioChem for manufacturing support and appointed Farrell Simon, Ph…
